CLB FY 2012 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2012 Earnings

Reported February 15, 2013

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2012	Prior Q	FY 2011	QoQ Change	YoY Change
Revenue	$981M	—	$908M	—	8.1%
Op. Income	$297M	—	$251M	—	18.6%
Gross Margin	34.3%	—	34.6%	—	-0.3pp
Net Margin	22.0%	—	20.3%	—	1.7pp
EPS (Diluted)	$4.54	—	$3.82	—	18.8%
Free Cash Flow	$204M	—	$174M	—	17.5%

Revenue Flow

Item	Amount
REVENUE	$981M
Cost of Revenue	$645M
GROSS PROFIT	$336M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$43M
SG&A Expenses	$43M
Other Expenses	$0
Operating Expenses	$43M
Cost & Expenses	$688M
OPERATING INCOME	$297M
Interest Income	$319.0K
Interest Expense	$9M
Other Income/Expenses	-$9M
INCOME BEFORE TAX	$288M
Income Tax Expense	$72M
Net Income from Continuing Ops	$216M
Net Income from Discontinued Ops	$0
Other Adjustments	$646.0K
NET INCOME	$216M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$216M
D&A	$23M
EBIT	$297M
EBITDA	$317M
EPS	$5
EPS Diluted	$5

Income Statement

Item	Amount
REVENUE	$981M
Cost of Revenue	$645M
GROSS PROFIT	$336M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$43M
SG&A Expenses	$43M
Other Expenses	$0
Operating Expenses	$43M
Cost & Expenses	$688M
OPERATING INCOME	$297M
Interest Income	$319.0K
Interest Expense	$9M
Other Income/Expenses	-$9M
INCOME BEFORE TAX	$288M
Income Tax Expense	$72M
Net Income from Continuing Ops	$216M
Net Income from Discontinued Ops	$0
Other Adjustments	$646.0K
NET INCOME	$216M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$216M
D&A	$23M
EBIT	$297M
EBITDA	$317M
EPS	$5
EPS Diluted	$5

Cash Flow Statement

Item	Amount
Net Income	$217M
Depreciation & Amortization	$23M
Stock-Based Compensation	$18M
Deferred Income Tax	$4M
Other Non-Cash Items	-$894.0K
Change in Working Capital	-$23M
OPERATING CASH FLOW	$237M
Capital Expenditure	-$33M
Acquisitions (Net)	-$878.0K
Purchases of Investments	-$3M
Sales/Maturities of Investments	$101.0K
Other Investing Activities	-$30M
NET CASH FROM INVESTING	-$34M
Net Debt Issuance	$9M
Common Stock Repurchased	-$176M
Common Dividends Paid	-$53M
Other Financing Activities	$7M
NET CASH FROM FINANCING	-$213M
FREE CASH FLOW	$204M
Net Change in Cash	-$10M

Balance Sheet

Item	Amount
Cash & Equivalents	$19M
Short-Term Investments	$0
Net Receivables	$203M
Inventory	$49M
Other Current Assets	$11M
TOTAL CURRENT ASSETS	$297M
PP&E (Net)	$125M
Goodwill	$163M
Intangible Assets	$9M
Long-Term Investments	$2M
Tax Assets	$13M
Other Non-Current Assets	-$15M
TOTAL NON-CURRENT ASSETS	$340M
TOTAL ASSETS	$637M
Account Payables	$55M
Short-Term Debt	$0
Deferred Revenue	$14M
Other Current Liabilities	$15M
TOTAL CURRENT LIABILITIES	$141M
Long-Term Debt	$234M
Deferred Revenue NC	-$7M
Deferred Tax Liabilities	$7M
Other Non-Current Liabilities	$67M
TOTAL NON-CURRENT LIABILITIES	$308M
TOTAL LIABILITIES	$449M
Common Stock	$1M
Additional Paid-In Capital	$0
Retained Earnings	$361M
Treasury Stock	-$172M
Accum. Other Comp. Income	-$8M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$188M
Minority Interest	$6M
TOTAL EQUITY	$194M
TOTAL LIABILITIES & EQUITY	$637M
Total Debt	$234M
Net Debt	$215M